Payment overview · 2025
General Payments
$54.34
3 reported records · 3 companies
Healthcare provider profile · identity verified
David Wayne French, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · EDDYVILLE, KY · NPI 1649336306
Verified facts
What the public records show
CMS Open Payments records show David Wayne French, M.D. received $54.34 in general payments during 2025 across 3 reported records.
Novartis Pharmaceuticals Corporation accounted for 44.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Entresto by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $24.18 | 44.5% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.21 | 28.0% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $14.95 | 27.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $54.34 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $24.18 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.21 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $14.95 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 762 | 143 |
| Atorvastatin Calcium | Atorvastatin Calcium | 689 | 147 |
| Lisinopril | Lisinopril | 672 | 135 |
| Furosemide | Furosemide | 479 | 84 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 475 | 89 |
| Gabapentin | Gabapentin | 416 | 86 |
| Amlodipine Besylate | Amlodipine Besylate | 404 | 96 |
| Simvastatin | Simvastatin | 382 | 78 |
| Potassium Chloride | Potassium Chloride | 347 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 343 | 90 |
| Famotidine | Famotidine | 333 | 47 |
| Omeprazole | Omeprazole | 316 | 82 |
| Trazodone Hcl | Trazodone Hcl | 310 | 61 |
| Losartan Potassium | Losartan Potassium | 288 | 70 |
| Metformin Hcl | Metformin Hcl | 254 | 63 |
| Alprazolam | Alprazolam | 245 | 43 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 239 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 235 | 57 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 235 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 220 | 63 |
| Tamsulosin Hcl | Tamsulosin Hcl | 218 | 56 |
| Meloxicam | Meloxicam | 207 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 206 | 44 |
| Tizanidine Hcl | Tizanidine Hcl | 200 | 45 |
| Eliquis | Apixaban | 190 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 188 | 47 |
| Carvedilol | Carvedilol | 180 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 170 | 56 |
| Escitalopram Oxalate | Escitalopram Oxalate | 169 | 42 |
| Clonazepam | Clonazepam | 168 | 27 |
| Tramadol Hcl | Tramadol Hcl | 163 | 29 |
| Lorazepam | Lorazepam | 158 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 156 | 41 |
| Quetiapine Fumarate | Quetiapine Fumarate | 155 | 27 |
| Clonidine Hcl | Clonidine Hcl | 143 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 141 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 140 | 32 |
| Allopurinol | Allopurinol | 138 | 24 |
| Ondansetron Hcl | Ondansetron Hcl | 135 | 31 |
| Buspirone Hcl | Buspirone Hcl | 131 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 127 | 34 |
| Sertraline Hcl | Sertraline Hcl | 126 | 29 |
| Atenolol | Atenolol | 117 | 14 |
| Mirtazapine | Mirtazapine | 113 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 23 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 111 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 103 | 81 |
| Montelukast Sodium | Montelukast Sodium | 103 | 26 |
| Pravastatin Sodium | Pravastatin Sodium | 102 | 19 |
| Glipizide | Glipizide | 95 | 12 |
| Januvia | Sitagliptin Phosphate | 95 | 16 |
| Meclizine Hcl | Meclizine Hcl | 94 | 31 |
| Donepezil Hcl | Donepezil Hcl | 93 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 85 | 20 |
| Spironolactone | Spironolactone | 83 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 82 | 27 |
| Divalproex Sodium Er | Divalproex Sodium | 79 | suppressed |
| Levetiracetam | Levetiracetam | 79 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 76 | suppressed |
| Olanzapine | Olanzapine | 76 | suppressed |
| Risperidone | Risperidone | 76 | 11 |
| Lactulose | Lactulose | 75 | 11 |
| Ozempic | Semaglutide | 73 | 16 |
| Bumetanide | Bumetanide | 70 | 15 |
| Nabumetone | Nabumetone | 68 | 18 |
| Cephalexin | Cephalexin | 67 | 58 |
| Divalproex Sodium | Divalproex Sodium | 67 | suppressed |
| Prednisone | Prednisone | 67 | 45 |
| Farxiga | Dapagliflozin Propanediol | 66 | 14 |
| Linzess | Linaclotide | 65 | 14 |
| Ezetimibe | Ezetimibe | 63 | 15 |
| Pregabalin | Pregabalin | 62 | 13 |
| Testosterone Cypionate | Testosterone Cypionate | 62 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 62 | 13 |
| Diazepam | Diazepam | 61 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 58 | 37 |
| Naltrexone Hcl | Naltrexone Hcl | 58 | suppressed |
| Finasteride | Finasteride | 57 | 11 |
| Methylprednisolone | Methylprednisolone | 57 | 44 |
| Ketoconazole | Ketoconazole | 55 | 23 |
| Lamotrigine | Lamotrigine | 54 | suppressed |
| Memantine Hcl | Memantine Hcl | 54 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 54 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 53 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 52 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 52 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 51 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 49 | 20 |
| Jardiance | Empagliflozin | 49 | 13 |
| Xarelto | Rivaroxaban | 48 | suppressed |
| Celecoxib | Celecoxib | 46 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 46 | 17 |
| Doxepin Hcl | Doxepin Hcl | 46 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | 12 |
| Nystatin | Nystatin | 45 | 20 |
| Promethazine Hcl | Promethazine Hcl | 45 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 30 |
| Warfarin Sodium | Warfarin Sodium | 44 | suppressed |
| Ibuprofen | Ibuprofen | 43 | suppressed |
| Temazepam | Temazepam | 43 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 43 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 42 | suppressed |
| Indapamide | Indapamide | 42 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 42 | suppressed |
| Latanoprost | Latanoprost | 41 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 40 | suppressed |
| Synthroid | Levothyroxine Sodium | 40 | 12 |
| Trulicity | Dulaglutide | 39 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 38 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 37 | suppressed |
| Fluconazole | Fluconazole | 37 | 14 |
| Sevelamer Carbonate | Sevelamer Carbonate | 37 | suppressed |
| Azithromycin | Azithromycin | 36 | 34 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 36 | suppressed |
| Myrbetriq | Mirabegron | 36 | suppressed |
| Aripiprazole | Aripiprazole | 35 | suppressed |
| Novolog Flexpen | Insulin Aspart | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | 12 |
| Albuterol Sulfate | Albuterol Sulfate | 33 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 26 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | 11 |
| Levofloxacin | Levofloxacin | 33 | 23 |
| Topiramate | Topiramate | 33 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 25 |
| Estradiol | Estradiol | 32 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 31 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 31 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 31 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 28 | suppressed |
| Sucralfate | Sucralfate | 28 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 27 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 20 |
| Bupropion Hcl | Bupropion Hcl | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 25 | suppressed |
| Torsemide | Torsemide | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Fentanyl | Fentanyl | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Lacosamide | Lacosamide | 24 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | 18 |
| Ziprasidone Hcl | Ziprasidone Hcl | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Loperamide | Loperamide Hcl | 22 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 17 |
| Ondansetron Odt | Ondansetron | 21 | 13 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | 11 |
| Primidone | Primidone | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 17 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Folic Acid | Folic Acid | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 18 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Gemtesa | Vibegron | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 15 | suppressed |
| Carisoprodol | Carisoprodol | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | 11 |
| Thioridazine Hcl | Thioridazine Hcl | 15 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Erythromycin | Erythromycin Base | 13 | suppressed |
| Fycompa | Perampanel | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Nadolol | Nadolol | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Ubrelvy | Ubrogepant | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Entecavir | Entecavir | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 12 | suppressed |
| Guanfacine Hcl Er | Guanfacine Hcl | 12 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Trospium Chloride | Trospium Chloride | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Vyvanse | Lisdexamfetamine Dimesylate | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Indomethacin | Indomethacin | 11 | suppressed |
| Levocarnitine | Levocarnitine | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $54.34 · 3 records | Novartis Pharmaceuticals Corporation | Cologuard Collection Kit, LEQVIO, VOQUEZNA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novartis Pharmaceuticals Corporation?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error